Graphene oxide-enhanced dissolvable microneedles for transdermal delivery of alendronate: Augmented permeation and antibacterial activity
Journal of Biomaterials Applications
Published online on June 02, 2026
Abstract
Journal of Biomaterials Applications, Ahead of Print.
Osteoporosis treatment using alendronate (ALN) is limited by poor oral bioavailability and gastrointestinal side effects. To address this limitation, this study developed a graphene oxide (GO)-enhanced soluble microneedle (MN) system for transdermal ...
Osteoporosis treatment using alendronate (ALN) is limited by poor oral bioavailability and gastrointestinal side effects. To address this limitation, this study developed a graphene oxide (GO)-enhanced soluble microneedle (MN) system for transdermal ...